Skip to main content

Advertisement

SpringerLink
Log in

The hidden sentinel node and SPECT/CT in breast cancer patients

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

In a minority of breast cancer patients, lymphoscintigraphy shows no lymphatic drainage and ‘hidden’ sentinel nodes may remain undiscovered. The purpose of this study was to explore the additional value of the recently introduced hybrid SPECT/CT in breast cancer patients with axillary non-visualisation on planar images. The role of blue dye and careful palpation of the axilla was evaluated in patients in whom axillary sentinel nodes remained hidden after SPECT/CT.

Methods

Fifteen breast cancer patients with non-visualisation on planar lymphoscintigraphy and 13 women with only extra-axillary sentinel nodes underwent SPECT/CT following late planar imaging without re-injection of the radiopharmaceutical.

Results

SPECT/CT visualised lymphatic drainage in eight of the 15 patients (53%) with non-visualisation on planar imaging, depicted nine of the 14 harvested sentinel nodes (64%) and three of five tumour-positive sentinel nodes. In two of the 13 patients (15%) with only extra-axillary sentinel nodes on their planar lymphoscintigram, SPECT/CT showed an axillary sentinel node that appeared to be uninvolved. Careful exploration of the axilla with the combined use of blue dye, a gamma probe and intra-operative palpation revealed an axillary sentinel node in the remaining 18 patients. SPECT/CT showed the exact anatomical location of all visualised sentinel nodes.

Conclusion

SPECT/CT discovered ‘hidden’ sentinel nodes in the majority of patients with non-visualisation, but was less valuable in patients with only extra-axillary lymphatic drainage on the planar images. Exploration of the axilla in patients with persistent non-visualisation improved the identification of axillary (involved) sentinel nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nieweg OE, Estourgie SH, Valdés Olmos RA, et al. Lymphatic mapping with tracer administration into the primary breast cancer. Eur J Surg Oncol 2003;29:95–7.

    Article  PubMed  CAS  Google Scholar 

  2. Rutgers EJ, Jansen L, Nieweg OE, et al. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 1998;24:316–9.

    Article  PubMed  CAS  Google Scholar 

  3. d’Eredita G, Serio G, Mele M, et al. Effect of the use of vital dye, lymphoscintigraphy, or a combination for axillary lymphatic mapping and sentinel node biopsy in breast cancer. World J Surg 2002;26:588–90.

    Article  PubMed  Google Scholar 

  4. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–66.

    PubMed  CAS  Google Scholar 

  5. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473–8.

    Article  PubMed  CAS  Google Scholar 

  6. Chakera AH, Friis E, Hesse U, et al. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005;32:286–93.

    Article  PubMed  CAS  Google Scholar 

  7. Krausz Y, Ikeda DM, Jadvar H, et al. Non-visualization of sentinel lymph node in patients with breast cancer. Nucl Med Commun 2001;22:25–32.

    Article  PubMed  CAS  Google Scholar 

  8. Kroon BK, Valdés Olmos R, Nieweg OE, et al. Non-visualization of sentinel lymph nodes in penile carcinoma. Eur J Nucl Med Mol Imaging 2005;32:1096–99.

    Article  PubMed  Google Scholar 

  9. Tanis PJ, van Sandick JW, Nieweg OE, et al. The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging 2002;29:305–11.

    Article  PubMed  CAS  Google Scholar 

  10. Even-Sapir E, Lerman H, Lievshitz G, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003;44:1413–20.

    PubMed  Google Scholar 

  11. Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003;33:205–18.

    Article  PubMed  Google Scholar 

  12. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 2000;27:619–27.

    Article  PubMed  CAS  Google Scholar 

  13. Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging? Eur J Nucl Med Mol Imaging 2005;32:521–4.

    Article  PubMed  Google Scholar 

  14. Husarik DB, Steinert HC. Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer. Semin Nucl Med 2007;37:29–33.

    Article  PubMed  Google Scholar 

  15. Lerman H, Metser U, Lievshitz G, et al. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging 2006;33:329–37.

    Article  PubMed  CAS  Google Scholar 

  16. Lerman H, Lievshitz G, Zak O, et al. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 2007;48:201–6.

    PubMed  Google Scholar 

  17. van der Ploeg IM, Valdés Olmos RA, Nieweg OE, et al. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med 2007;48:1756–60.

    Article  PubMed  Google Scholar 

  18. Nieweg OE, Tanis PJ, Kroon BB. The definition of a sentinel node. Ann Surg Oncol 2001;8:538–41.

    Article  PubMed  CAS  Google Scholar 

  19. Suami H, Pan WR, Mann GB, et al. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 2008;15:863–71.

    Article  PubMed  Google Scholar 

  20. Tanis PJ, Nieweg OE, Valdés Olmos RA, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001;192:399–409.

    Article  PubMed  CAS  Google Scholar 

  21. Tanis PJ, van Rijk MC, Nieweg OE. The posterior lymphatic network of the breast rediscovered. J Surg Oncol 2005;91:195–8.

    Article  PubMed  Google Scholar 

  22. Uren RF, Howman-Giles R, Renwick SB, et al. Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg 2001;25:789–93.

    Article  PubMed  CAS  Google Scholar 

  23. Goyal A, Newcombe RG, Mansel RE, et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 2005;41:238–43.

    Article  PubMed  Google Scholar 

  24. Valdés Olmos RA, Jansen L, Hoefnagel CA, et al. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med 2000;41:1500–506.

    PubMed  Google Scholar 

  25. Valdés Olmos RA, Tanis PJ, Hoefnagel CA, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001;22:579–86.

    Article  PubMed  Google Scholar 

  26. Byrd DR, Dunnwald LK, Mankoff DA, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 2001;8:234–40.

    Article  PubMed  CAS  Google Scholar 

  27. Bass SS, Lyman GH, McCann CR, et al. Lymphatic mapping and sentinel lymph node biopsy. Breast J 1999;5:288–95.

    Article  PubMed  Google Scholar 

  28. Brenot-Rossi I, Houvenaeghel G, Jacquemier J, et al. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? J Nucl Med 2003;44:1232–37.

    PubMed  Google Scholar 

  29. Estourgie SH, Valdés Olmos RA, Nieweg OE. Reproducibility of sentinel node lymphoscintigraphy after excisional biopsy of breast lesions. Eur J Nucl Med Mol Imaging 2004;31:S296.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    Iris M. C. van der Ploeg, Bin B. R. Kroon, Emiel J. T. Rutgers & Omgo E. Nieweg

  2. Department of Nuclear Medicine, The Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    Renato A. Valdés Olmos

Authors
  1. Iris M. C. van der Ploeg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renato A. Valdés Olmos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin B. R. Kroon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emiel J. T. Rutgers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Omgo E. Nieweg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iris M. C. van der Ploeg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Ploeg, I.M.C., Valdés Olmos, R.A., Kroon, B.B.R. et al. The hidden sentinel node and SPECT/CT in breast cancer patients. Eur J Nucl Med Mol Imaging 36, 6–11 (2009). https://doi.org/10.1007/s00259-008-0910-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0910-2

Keywords

Search

Navigation